Glycan antagonists and inhibitors: A fount for drug discovery

  • Brown J
  • Crawford B
  • Esko J
  • 54


    Mendeley users who have this article in their library.
  • 52


    Citations of this article.


Glycans, the carbohydrate chains of glycoproteins, proteoglycans, and glycolipids, represent a relatively unexploited area for drug development compared with other macromolecules. This review describes the major classes of glycans synthesized by animal cells, their mode of assembly, and available inhibitors for blocking their biosynthesis and function. Many of these agents have proven useful for studying the biological activities of glycans in isolated cells, during embryological development, and in physiology. Some are being used to develop drugs for treating metabolic disorders, cancer, and infection, suggesting that glycans are excellent targets for future drug development.

Author-supplied keywords

  • Carbohydrates
  • Glycans
  • Glycosylation
  • Inhibitors
  • Therapeutics

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • Jillian R. Brown

  • Brett E. Crawford

  • Jeffrey D. Esko

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free